Genentech has signed a $1bn collaboration deal with Lodo Therapeutics to develop unique, natural products from the microbial DNA found in soil. With this level of investment confidence must be high, but just how much potential lies in soil, and how can it be harnessed? Sally Turner finds out in the new issue of Pharma Technology Focus.